Quentin Vanhaelen, PhD (IMAGE) InSilico Medicine Caption Quentin Vanhaelen, PhD, of Insilico Medicine will present on the Company's AI-powered target discovery platform PandaOmics at the 9th annual Aging Research and Drug Discovery conference. Credit c/o Insilico Medicine Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.